Literature DB >> 11072098

Induction of neuronal apoptosis by Semaphorin3A-derived peptide.

A Shirvan1, R Shina, I Ziv, E Melamed, A Barzilai.   

Abstract

Collapsin-1/Semaphorin3A (Sema3A) belongs to the secreted type III semaphorins family of axon guidance molecules with chemorepulsive activity, and is suggested to play a major role in navigating axonal networks throughout development into their correct destinations. We have previously shown that semaphorins are mediators of neuronal apoptosis and can induce neuronal death in the absence of any other apoptotic trigger. We report here that exposure of neuronal cells to a small conserved peptide derived from Sema3A initiates an apoptotic death process. Administration of this peptide to cultured chick sympathetic and mouse cerebellar granule neurons caused a marked shrinkage of their axonal network and cell death, which was characterized as apoptotic, based on nuclear staining. Attenuation of neuronal cell death was obtained by treatment with antioxidants and by vascular endothelial growth factor. Survival of neurons exposed to this peptide increased by co-treatment with caspase inhibitors. Induction of apoptosis was specific to neuronal cells, similarly to that induced by the full-length Sema3A protein. Our findings therefore suggest active participation of this conserved Sema3A-derived peptide in semaphorin-induced neuronal death process.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11072098     DOI: 10.1016/s0169-328x(00)00198-4

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  12 in total

1.  Calpain-cleaved collapsin response mediator protein-3 induces neuronal death after glutamate toxicity and cerebral ischemia.

Authors:  Sheng T Hou; Susan X Jiang; Angele Desbois; Deqi Huang; John Kelly; Luc Tessier; Laurie Karchewski; Joachim Kappler
Journal:  J Neurosci       Date:  2006-02-22       Impact factor: 6.167

Review 2.  Stress-induced remodeling of lymphoid innervation.

Authors:  Erica K Sloan; John P Capitanio; Steve W Cole
Journal:  Brain Behav Immun       Date:  2007-08-13       Impact factor: 7.217

3.  Inhibitory effects of Semaphorin 3F as an alternative candidate to anti-VEGF monoclonal antibody on angiogenesis.

Authors:  Gamze Tan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2019-08-16       Impact factor: 2.416

4.  High-resolution whole-genome association study of Parkinson disease.

Authors:  Demetrius M Maraganore; Mariza de Andrade; Timothy G Lesnick; Kari J Strain; Matthew J Farrer; Walter A Rocca; P V Krishna Pant; Kelly A Frazer; David R Cox; Dennis G Ballinger
Journal:  Am J Hum Genet       Date:  2005-09-09       Impact factor: 11.025

5.  Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect.

Authors:  Emely Castro-Rivera; Sophia Ran; Philip Thorpe; John D Minna
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-23       Impact factor: 11.205

Review 6.  Physiological functions of non-apoptotic caspase activity in the nervous system.

Authors:  Emilie Hollville; Mohanish Deshmukh
Journal:  Semin Cell Dev Biol       Date:  2017-12-07       Impact factor: 7.727

Review 7.  Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics.

Authors:  Ling Lin; Timothy G Lesnick; Demetrius M Maraganore; Ole Isacson
Journal:  Trends Neurosci       Date:  2009-01-21       Impact factor: 13.837

Review 8.  Roles of semaphorins in the immune and hematopoietic system.

Authors:  Jong Dae Ji; Lionel B Ivashkiv
Journal:  Rheumatol Int       Date:  2009-01-13       Impact factor: 3.580

9.  Dopaminergic axon guidance: which makes what?

Authors:  Laetitia Prestoz; Mohamed Jaber; Afsaneh Gaillard
Journal:  Front Cell Neurosci       Date:  2012-07-31       Impact factor: 5.505

10.  A genomic pathway approach to a complex disease: axon guidance and Parkinson disease.

Authors:  Timothy G Lesnick; Spiridon Papapetropoulos; Deborah C Mash; Jarlath Ffrench-Mullen; Lina Shehadeh; Mariza de Andrade; John R Henley; Walter A Rocca; J Eric Ahlskog; Demetrius M Maraganore
Journal:  PLoS Genet       Date:  2007-06       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.